1st Case To Go To Trial In Neurontin MDL Dropped
The first individual case to go to trial in the multidistrict litigation over Pfizer Inc.'s alleged campaign to increase profits of Neurontin by encouraging doctors to prescribe the anti-epilepsy drug for...To view the full article, register now.
Already a subscriber? Click here to view full article